ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 131 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $222,000 | -1.3% | 18,082 | -8.0% | 0.00% | 0.0% |
| Q2 2017 | $225,000 | -48.7% | 19,650 | -6.9% | 0.00% | -50.0% |
| Q1 2017 | $439,000 | +0.5% | 21,100 | +0.5% | 0.01% | -14.3% |
| Q4 2016 | $437,000 | -35.1% | 21,000 | +2.3% | 0.01% | -41.7% |
| Q3 2016 | $673,000 | +31.2% | 20,532 | 0.0% | 0.01% | +20.0% |
| Q2 2016 | $513,000 | +2.0% | 20,532 | 0.0% | 0.01% | -9.1% |
| Q1 2016 | $503,000 | -29.7% | 20,532 | -5.1% | 0.01% | -45.0% |
| Q4 2015 | $715,000 | +0.8% | 21,632 | 0.0% | 0.02% | +5.3% |
| Q3 2015 | $709,000 | -40.4% | 21,632 | -3.6% | 0.02% | -34.5% |
| Q2 2015 | $1,189,000 | +51.3% | 22,440 | -17.7% | 0.03% | +45.0% |
| Q1 2015 | $786,000 | – | 27,250 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 1,628,328 | $33,869,000 | 14.72% |
| Foresite Capital Management II, LLC | 995,396 | $20,704,000 | 10.39% |
| Cormorant Asset Management, LP | 1,581,604 | $32,897,000 | 4.43% |
| DAFNA Capital Management LLC | 221,013 | $4,597,000 | 4.04% |
| New Leaf Venture Partners, L.L.C. | 228,428 | $4,751,000 | 3.40% |
| Partner Investment Management, L.P. | 63,571 | $1,322,000 | 1.75% |
| Iguana Healthcare Management, LLC | 140,000 | $2,912,000 | 1.74% |
| PFM Health Sciences, LP | 2,913,951 | $60,610,000 | 1.71% |
| Redmile Group, LLC | 920,550 | $19,147,000 | 1.65% |
| SECTORAL ASSET MANAGEMENT INC | 669,351 | $13,923,000 | 1.54% |